Lobbying Relationship

Client

Novartis Corporation

More records

Lobbying firm

THE DUBERSTEIN GROUP, INC.

More records

  • Tax policy - HR 4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.
  • Vaccine policy - Executive Branch action re this issue.

Duration: to

General Issues: Taxation/Internal Revenue Code, Pharmacy, Health Issues, Copyright/Patent/Trademark, Medical/Disease Research/Clinical Labs, Government Issues

Spending: about $1,200,000 (But it's complicated. Here's why.)

Agencies lobbied since 2007: House of Representatives, U.S. Senate, U.S. Senate,, White House Office, Office of Management & Budget (OMB), Natl Security Council (NSC), Office of the Vice President of the United States

Bills mentioned

H.R.4853: Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act...

Sponsor: James L. Oberstar (D-Minn.)

H.R.4213: Unemployment Compensation Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.1586: FAA Air Transportation Modernization and Safety Improvement Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4849: Small Business and Infrastructure Jobs Tax Act of 2010

Sponsor: Sander M. Levin (D-Mich.)

H.R.4899: Supplemental Appropriations Act, 2010

Sponsor: David R. Obey (D-Wis.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.1679: Affordable Health Choices Act

Sponsor: Tom Harkin (D-Iowa)

S.1796: America's Healthy Future Act of 2009

Sponsor: Max Baucus (D-Mont.)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.726: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

H.R.2346: Supplemental Appropriations Act, 2009

Sponsor: David R. Obey (D-Wis.)

S.1054: Supplemental Appropriations Act, 2009

Sponsor: Daniel K. Inouye (D-Hawaii)

S.515: Patent Reform Act of 2009

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1: American Recovery and Reinvestment Act of 2009

Sponsor: David R. Obey (D-Wis.)

H.R.1105: Omnibus Appropriations Act, 2009

Sponsor: David R. Obey (D-Wis.)

H.R.2638: Consolidated Security, Disaster Assistance, and Continuing...

Sponsor: David E. Price (D-N.C.)

H.R.7110: Job Creation and Unemployment Relief Act of 2008

Sponsor: David R. Obey (D-Wis.)

S.3604: Economic Recovery Act, 2008

Sponsor: Harry Reid (D-Nev.)

S.1145: Patent Reform Act of 2007

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1908: Patent Reform Act of 2007

Sponsor: Howard L. Berman (D-Calif.)

H.R.2642: Supplemental Appropriations Act, 2008

Sponsor: Chet Edwards (D-Texas)

H.R.1038: Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007

Sponsor: Jay Inslee (D-Wash.)

S.623: Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

S.1505: Affordable Biologics for Consumers Act

Sponsor: Judd Gregg (R-N.H.)

S.1695: Biologics Price Competition and Innovation Act of 2007

Sponsor: Edward M. Kennedy (D-Mass.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Steven Champlin ExecFlrAsst, H. Maj. Whip; ExecDir, H.DemCauc.
Kenneth Duberstein Chief of Staff, President Reagan
Brian Griffin StaffAsst, DemPolicyComm; FlrAsst, MinoritySec Sr. Ldrship Advisor, Sen. Dorgan
Eric Ueland Chief of Staff, Senator Bill Frist AsstEditor/Ed./Res.Dir, Sen.Rep.PolicyComm; PressSec/Economist/Policy&CommunicationsDir. Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLd COS, Sen.RulesComm; TransitionStaff Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr. COS, Sen.RulesComm; Transition Staff COS, Sen.RulesComm; TransitionStaff,
Marti Thomas Asst to COS to Maj. Ldr Gephardt Flr Aide & Exec.Flr Asst. to Maj. Ldr Gephardt Deputy Asst Sec Tax & Budget, Treasury Acting & Asst Sec. Legis. Affrs, Treasury
Daniel Meyer Admin. Asst, Cong. Vin Weber Chief of Staff, Speaker Newt Gingrich Asst. to President,Legis.Affairs, Pres. GW Bush
Michael Berman n/a
Henry Gandy n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page